Background
Methods
Study population
Collection of study population characteristics
Statistical analyses
Results
ICPC and chart findings
Patient characteristics
PE group (n = 35) | Control group (n = 150) |
P
| |
---|---|---|---|
Nullipara (%) | 75.8 | 58.7 |
0.07
‡
|
Mean age (y) ± SD | 31.9 ± 3.6 | 32.4 ± 3.8 | 0.49†
|
Hypertension in previous pregnancy (%) | 5.7 | 3.3 | 0.62§
|
Chronic hypertension (%) | 14.3 | 4.0 | 0.02‡
|
Pre-existing vascular disease (%) | 0.0 | 0.7 | 1.00§
|
Follow-up and risk factor management
PE Group (n = 35) | Control Group (n = 150) |
P
| |
---|---|---|---|
Mean follow-up time (y) ± SD | 2.9 (1.9) | 2.5 (1.8) | 0.29†
|
Blood pressure control | 20 (57.1) | 18 (12.0) | < 0.001§
|
Frequency | |||
1 time
|
5 (25.0)
|
10 (55.6)
| |
2 times
|
3 (15.0)
|
4 (22.2)
| |
≥ 3 times
|
13 (65.0)
|
4 (22.2)
| |
Indication | |||
PE/partus related
|
14 (70.0)
|
2 (11.8)
| |
Hypertension
|
6 (30.0)
|
5 (29.4)
| |
Complaints of vascular disease
|
0 (0.0)
|
5 (29.4)
| |
Screening/control
|
0 (0.0)
|
5 (29.4)
| |
Timing | |||
0-4 wks
|
7 (35.0)
|
3 (16.7)
| |
4-12 wks
|
4 (15.0)
|
0 (0.0)
| |
12-26 wks
|
5 (25.0)
|
0 (0.0)
| |
26-52 wks
|
0 (0.0)
|
0 (0.0)
| |
≥ 52 wks
|
5 (25.0)
|
15 (83.3)
| |
Glucose control | 1 (3.0) | 5 (3.3) | 1.00‡
|
Cholesterol control | 3 (9.1) | 7 (4.7) | 0.39‡
|
Cardiovascular diagnoses | |||
Hypertension*> 3 months postpartum | 6/30**(20.0) | 0 (0.0) | < 0.001‡
|
Hypercholesterolemia | 0 (0.0) | 1 (0.7) | 1.00‡
|
Gestational hypertensive disorder | 2 (6.1) | 1 (0.7) | 0.08‡
|
Cardio-/cerebrovascular disorder | 1 (3.0) | 3 (2.0) | 1.00‡
|